Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+137.7%
5Y CAGR+140.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+137.7%/yr
vs +199.1%/yr prior
5Y CAGR
+140.7%/yr
Recent deceleration
Acceleration
-61.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
80.8x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $307.37M | +404.6% |
| 2024 | $60.91M | +7.8% |
| 2023 | $56.52M | +146.9% |
| 2022 | $22.89M | +151.6% |
| 2021 | $9.10M | +139.2% |
| 2020 | $3.81M | +16.0% |
| 2019 | $3.28M | +1046.5% |
| 2018 | $286000.00 | +921.4% |
| 2017 | $28000.00 | +27.3% |
| 2016 | $22000.00 | - |